Bibliography

American Society for Aesthetic Plastic Surgery. Quick Facts: Highlights of the ASAPS 2007 Statistics on Cosmetic Surgery. Available at: http://www.surgery.org. Accessed March 17, 2008
Amin SP, Phelps RG, Goldberg DJ. (2006) Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg; 32: 1467-72.
Angus JE, Affleck AG, leach IH, Millard LG. (2006) Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel. Br J Dermatol. Nov;155(5):1077-8.
Balazs EA, Bland PA, Denlinger JL et al. (1991) Matrix engineering. Blood Coagul Fibrinolysis Feb;2(1):173-8.
Balazs EA, Denlinger JL (1989) Clinical uses of hyaluronan. Ciba Found Symp;143:265-75; discussion 275-80, 281-5.
Balazs EA, Leshchiner E, Larsen N, Band P. (1995) Hyaluronan biomaterials: medical applications. Wise DL, editor. Handbook of biomaterials and applications. New York: Marcel Dekker Inc: 1693-1715.
Balazs EA, Leshchiner EA. (1989) Hyaluronan its crosslinked derivative – hylan – and their medical applications. Inagaki H, Phillips GO, editors. Cellulosics utilization: research and rewards in cellulosics. Proceedings of Nisshinbo International Conference in Cellulosics Utilization in the Near Future;. New York: Elsevier Applied Science; 233-241.
Balazs EA. (1991) Medical application of hyaluronan and its derivates. Gebelein CG, Cheng F, Yang V, editors. Cosmetic and pharmaceutical application of polymers. London. Plenum Press;.293-310.
Bardazzi F, Ruffato A, Antonucci A, Balestri R, Tabanelli M. (2007) Cutaneous granulomatous reaction to injectable hyaluronic acid gel: another case. J Dermatolog Treat 18(1):59-62
Baumann L. (2004) Hyaluronic Acid in Fillers and Creams. Skin & Aging ISSN: 1096-0120 Vol 12 Issue 1 Jan: 86-88
Baumann L. (2006) Collagen-containing fillers: alone and in combination. Clin Plast Surg Oct;33(4):587-96
Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. (2007) Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg Dec;33 Suppl 2:S128-35
Bellman B. (2005) Immediate and delayed hypersensitivity reactions Restylane. Aesthetic Surgery Journal Volume 25, Issue 5, Sept-Oct, pages 489-491.
Bergeret-Galley C, Latouche X, Illouz YG. (2001) The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg Jul-Aug;25(4):249-55.
Bosniak S, Cantisano-Zilkha M, Purewal BK, Zdinak LA. (2006) Combination therapies in oculofacial rejuvenation. Orbit Dec;25(4):319-26.
Bosniak S, Cantisono-Zilkha M. (2001) Restylane and Perlane: A six year clinical experience. Operative Techniques in Oculoplastic, Orbital and Reconstructive Surgery Vol.4, No:2. 89-93.
Butterwick KJ, Nootheti PK, Hsu JW, et al. Autologous fat transfer: an in-depth look at varying concepts and techniques. Facial Plast Surg Clin North Am 15(1):99-111 (2007 Feb)
Carruthers A, Carruthers J. (2007) Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg Nov;120(6 Suppl):33S-40S
Carruthers J, Klein W, Carruthers et al. (2005) Safety and Efficacy of Hyaluronic acid for Mouth Corners. Dermatol Surg 31:279-280.
Carruthers JD, Glogau RG, Blitzer A. (2008) Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies–consensus recommendations. Plast Reconstr Surg May;121(5 Suppl):5S-30S; quiz 31S-36S
Centers for Disease Control prevention (CDC) Outbreak of mesotherapy assiciated skin reactions—District of Columbia-area. January-February 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1127-30.
DeLorenz C, Weinberg M, Solish N, Swift A. (2006) Multicenter study of the efficacy and safety of subcutaneous non-animal-stabilized hyaluronic acid in aesthetic facial contouring: interim report. Dermatol Surg Feb;32(2):205-11.
Duranti F, Salti G, Bovani B, Calandra M, Rosati ML (1998) Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg Dec;24(12):1317-25.
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 24 von 26
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 25von 26
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 26 von 26
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 27 von 26
Fernandez-Acenero J, Zamora E, Borbujo J. (2001) Granulomatous Foreign Body Reaction Against Hyaluronic Acid: Report of a Case after Lip Augmentaion. Dermatol Surg 29:1225-1226.
Fraser J.R.E., Laurent T.C., Engström-Laurent A. and Laurent U.G.B. (1984), Elimination of Hyaluronic Acid from the Blood Stream in the Human. Clinical and Experimental Pharmacology and Physiology, 11: 17-25.
Fraser JR, Laurent TC, Pertoft H, and Baxter E. (1981) Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J. November 15; 200(2): 415–424.
Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg Jun;28(6):491-4.
Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg Jun;28(6):491-4.
Goldman MP, Alster TS, Weiss R. (2007) A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment, and intense pulsed light therapy administered immediately after hyaluronic acid gel implantation. Dermatol Surg May;33(5):535-42.
Hamilton RG, Strobos J, Adkinson NF Jr. (2007) Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic ascid particles. Dermatol Surg Dec;33 Suppl 2:S176-85.
In Vivo Stimulation of De Novo Collagen Production Caused by Cross-Linked Hyaluronic Acid Dermal Filler Injections in Photodamaged Human Skin Wang F, Garza LA, Kang S, et al Arch Dermatol. 2007;143:155-163
Klein AW, Fagien S. (2007) Hyaluronic acid fillers and botulinum toxin type a: rationale for their individual and combined use for injectable facial rejuvenation. Plast Reconstr Surg 2007 Nov;120(6 Suppl):81S-88S
Landau M. (2006) Combination of chemical peelings with botulinum toxin injections and dermal fillers. J Cosmey Dermatol Jun;5(2):121-6
Lowe NJ, Grover R. Injectable hyaluronic acid implant for malar and mental enhancement. Dermatol Surg 32(7):881-5 (2006 Jul)
Lowe NJ, Maxwell CA, Patnaik R. (2007) Adverse reactions to dermal fillers: review. Dermatol Surg Nov;31(11 Pt 2):1616-25
Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC 3 rd . (2008) Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plastic Reconstr Surg Jan;121(1):289-97
Lupo MP. Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg 25(3):122-6 (2006 Sep)
Lupton JR, Alster TS. (2000) Cutaneous hypersensitivity reaction to injectable hyaluronic gel. Dermatol Surg 26:135-7
Moers-Carpi M, Vogt S, Santos BM et al. (2007) A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 33 Suppl 2:S144-51
Monheit GD, Prather CL. (2007) Juvéderm: a hyaluronic acid dermal filler. J Drugs Dermatol Nov;6(11):1091-5
Monstrey SJ, Pitaru S, Hamdi M, et al. A two-stage phase I trial of Evolence30 collagen for soft-tissue contour correction. Plast Reconstr Surg 120(1):303-11 (2007 Jul)
Narins RS, Brandt F, Leyden, Lorenc ZP, Rubin M, Smith S. (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg Jun;29(6):588-95
Narins RS, Brandt F, Leyden, Lorenc ZP, Rubin M, Smith S. (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg Jun;29(6):588-95.
ordan DR. (2005) Delayed inflammatory reaction to hyaluronic acid (Restylane). Ophthal Plast Reconstr Surg Sep;21(5):401-2.
PMA of Juvéderm (PMA P050047 – 02/06/2006) / Baumann LS, Shamban AT, Lupo MP et al. (2007) Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Dec;33 Suppl 2:S128-35.
PMA of Restylane Injectable Gel (PMA P020023 – 14/06/2003) / Narins RS, Brandt F, Leyden J et al. (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg Jun;29(6):588-95.
Preclinical Summary of Restylane P020023, FDA; http://www.fda.gov/ohrms/dockets/AC/03/briefing/4004b1_07_Preclinical%20Sum mary-Redacted.pdf
Raulin C, Greve B, Hartschuh W, Soegding K. (2000) Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis 43:178-9.
Requena C, Izquierdo MJ, Navarro M, Martinez A, Vilata JJ, Botella R, Amorrortu J, Sabater V, Aliaga A, Requena L. (2001) Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol Jun23(3):197-202.
Rohrich RJ, Ghavami A, Crosby MA (2007) The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg Nov;120(6 Suppl):41S-54S
Rohrich RJ, Pessa JE, RistowB. The youthful cheek and the deep medial fat compartment. Plast Reconstr Surg. 2008 Jun; 121(6) : 2107-12
Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007 Jun;119(7):2219-27; discussion 2228-31
Rzany B, de Maio M. (2006) Injectable Fillers in Aesthetic Medicine. Springer- Verlag Berlin and Heidelberg GmbH & Co. K.
Sidwell RU, Dhillon AP, Butler PE, Rustin MH. (2004) Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol Nov;29(6):630-2.
Smith KC. (2007) Practical use of Juvéderm: early experience. Plast Reconstr Surg Nov;120(6 Suppl):67S-73S.
Soparker CN, patrinely JR. (2005) Managing inflammatory reaction to Restylane. Ophthal Plast Reconstr Surg Mar,21(2):151-3
Tosti A, De Padova MP (2007) Atlas of Mesotherapy in skin rejuvenation.
Vargas-Machuca I, Gonzalez-Guerra E, Angulo J, del Carmen Farina M, Martin L, Requena L. (2006) Facial granulomas secondary to Dermalive microimplants: Report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am J Dermatopathol Apr;20(2):173-7.
Zielke H, Wölber L, Weist L, Rzany B. (2008) Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg Mar;34(3):326-35; discussion 335. Epub 2007 Dec 20.

WORLD WIDE DISTRIBUTION

Molderm® is distributed via and ONLY by an exclusive distribution network to ensure the same quality and identity, shared values and concept, no matter where you are located. You only have the opportunity to order your Molderm® products from the distributor who is responsible for the territory you are located in. Click on “see distributor list” down below to find your distributor.

Interested in getting exclusive distribution rights of Molderm® in your country? Please click on “become a distributor” for application and initial contact.